Showing results (51-60 of 138) with videos related to

Sort By:
Pageof 14
Neurology|December 1, 1988
Heterogeneous anterior-posterior metabolic patterns in dementia of the Alzheimer typeJ V Haxby, C L Grady, E Koss, et al.
Plos Pathogens|May 18, 2022
Regulation of epitope exposure in the gp41 membrane-proximal external region through interactions at the apex of HIV-1 EnvHannah M Schapiro, Mukta D Khasnis, Koree Ahn, et al.
Annals of Internal Medicine|June 15, 1996
The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patientsJ M Schapiro, M A Winters, F Stewart, et al.
Plos One|March 24, 2017
Development of an evidence evaluation and synthesis system for drug-drug interactions, and its application to a systematic review of HIV and malaria co-infectionKay Seden, Sara Gibbons, Catia Marzolini, et al.
The Journal of Antimicrobial Chemotherapy|September 11, 2008
A randomized, controlled study evaluating an induction treatment strategy in which enfuvirtide was added to an oral, highly active antiretroviral therapy regimen in treatment-experienced patients: the INTENSE studyBonaventura Clotet, Amedeo Capetti, Luis E Soto-Ramirez, et al.
Anesthesiology|July 1, 1989
Adverse effects of maternally administered lidocaine on the asphyxiated preterm fetal lambH O Morishima, H Pedersen, A C Santos, et al.
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|September 2, 2006
Update of the drug resistance mutations in HIV-1: Fall 2006Victoria A Johnson, Francoise Brun-Vezinet, Bonaventura Clotet, et al.
The Journal of Infectious Diseases|July 7, 2000
Methods for investigation of the relationship between drug-susceptibility phenotype and human immunodeficiency virus type 1 genotype with applications to AIDS clinical trials group 333A D Sevin, V DeGruttola, M Nijhuis, et al.
Vaccine|August 24, 2021
Semi-quantitative, high throughput analysis of SARS-CoV-2 neutralizing antibodies: Measuring the level and duration of immune response antibodies post infection/vaccinationSean C Taylor, Beth Hurst, Ian Martiszus, et al.
Antimicrobial Agents and Chemotherapy|July 20, 2007
In vitro antiviral activity and cross-resistance profile of PL-100, a novel protease inhibitor of human immunodeficiency virus type 1Serge Dandache, Guy Sévigny, Jocelyn Yelle, et al.
Pageof 14